Cargando…

Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells

The commonly mutated human KRAS oncogene encodes two distinct KRAS4A and KRAS4B proteins generated by differential splicing. We demonstrate here that coordinated regulation of both isoforms through control of splicing is essential for development of Kras mutant tumors. The minor KRAS4A isoform is en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wei-Ching, To, Minh D., Westcott, Peter M. K., Delrosario, Reyno, Kim, Il-Jin, Philips, Mark, Tran, Quan, Bollam, Saumya R., Goodarzi, Hani, Bayani, Nora, Mirzoeva, Olga, Balmain, Allan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277813/ https://www.ncbi.nlm.nih.gov/pubmed/34257283 http://dx.doi.org/10.1038/s41467-021-24498-7

Ejemplares similares

Gene networks reveal stem-cell state convergence during preneoplasia and progression to malignancy in multistage skin carcinogenesis
por: Taylor, Mark A., et al.
Publicado: (2023)

Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
por: Faust, Tyler, et al.
Publicado: (2019)

The mutational landscapes of genetic and chemical models of Kras-driven lung cancer
por: Westcott, Peter M. K., et al.
Publicado: (2014)

Allele-Specific Deletions in Mouse Tumors Identify Fbxw7 as Germline Modifier of Tumor Susceptibility
por: Perez-Losada, Jesus, et al.
Publicado: (2012)

Interactions Between Wildtype and Mutant Ras Genes in Lung and Skin Carcinogenesis
por: To, Minh D., et al.
Publicado: (2012)

Molecular basis of RNA-binding and autoregulation by the cancer-associated splicing factor RBM39
por: Campagne, Sébastien, et al.
Publicado: (2023)

Negative autoregulation of BMP dependent transcription by SIN3B splicing reveals a role for RBM39
por: Faherty, Noel, et al.
Publicado: (2016)

The role of KRAS splice variants in cancer biology
por: Nuevo-Tapioles, Cristina, et al.
Publicado: (2022)

The transcription factor c-Jun inhibits RBM39 to reprogram pre-mRNA splicing during genotoxic stress
por: Lemaitre, Florence, et al.
Publicado: (2022)

Arginine reprograms metabolism in liver cancer via RBM39
por: Mossmann, Dirk, et al.
Publicado: (2023)

Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay
por: Sun, Yue, et al.
Publicado: (2017)

Alternative Splicing Regulator RBM20 and Cardiomyopathy
por: Watanabe, Takeshi, et al.
Publicado: (2018)

The genetics and biology of KRAS in lung cancer
por: Westcott, Peter M. K., et al.
Publicado: (2013)

Rbm20 regulates titin alternative splicing as a splicing repressor
por: Li, Shijun, et al.
Publicado: (2013)

Alternative Splicing of Cdh23 Exon 68 Is Regulated by RBM24, RBM38, and PTBP1
por: Li, Nana, et al.
Publicado: (2020)

Phylogenetic and Molecular Characterization of the Splicing Factor RBM4
por: Lu, Chia-Chen, et al.
Publicado: (2013)

Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker
por: Zhang, Rui, et al.
Publicado: (2022)

E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial
por: Bewersdorf, Jan Philipp, et al.
Publicado: (2023)

Cardiomyopathy: RBM20 mutations impair splicing of cardiac genes
Publicado: (2012)

Tumor suppressor properties of the splicing regulatory factor RBM10
por: Hernández, Jordi, et al.
Publicado: (2016)

A bacterial virulence factor interacts with the splicing factor RBM5 and stimulates formation of nuclear RBM5 granules
por: Pourpre, Renaud, et al.
Publicado: (2022)

Multi-color lineage tracing reveals clonal dynamics of squamous carcinoma evolution from initiation to metastasis
por: Reeves, Melissa Q., et al.
Publicado: (2018)

Differential expression of RBM5 and KRAS in pancreatic ductal adenocarcinoma and their association with clinicopathological features
por: PENG, JIE, et al.
Publicado: (2013)

RBM39 Alters Phosphorylation of c-Jun and Binds to Viral RNA to Promote PRRSV Proliferation
por: Song, Yinna, et al.
Publicado: (2021)

Muscle-Specific Mis-Splicing and Heart Disease Exemplified by RBM20
por: Rexiati, Maimaiti, et al.
Publicado: (2018)

Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma
por: Zhang, Yong-Fa, et al.
Publicado: (2021)

Novel splicing‐site mutation in DCAF17 gene causing Woodhouse‐Sakati syndrome in a large consanguineous family
por: Fozia, Fozia, et al.
Publicado: (2021)

Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models
por: Singh, Shivendra, et al.
Publicado: (2021)

A Genetic Screen for Pre-mRNA Splicing Mutants of Arabidopsis thaliana Identifies Putative U1 snRNP Components RBM25 and PRP39a
por: Kanno, Tatsuo, et al.
Publicado: (2017)

Discovery of Nanomolar DCAF1 Small Molecule Ligands
por: Li, Alice Shi Ming, et al.
Publicado: (2023)

The splicing factor RBM25 controls MYC activity in acute myeloid leukemia
por: Ge, Ying, et al.
Publicado: (2019)

Structural basis of UCUU RNA motif recognition by splicing factor RBM20
por: Upadhyay, Santosh Kumar, et al.
Publicado: (2020)

The skeletal muscle circadian clock regulates titin splicing through RBM20
por: Riley, Lance A, et al.
Publicado: (2022)

Structural basis for specific RNA recognition by the alternative splicing factor RBM5
por: Soni, Komal, et al.
Publicado: (2023)

Characterization of TTN Novex Splicing Variants across Species and the Role of RBM20 in Novex-Specific Exon Splicing
por: Chen, Zhilong, et al.
Publicado: (2018)

Overlaid Transcriptional and Proteome Analyses Identify Mitotic Kinesins as Important Targets of Arylsulfonamide-Mediated RBM39 Degradation
por: Coomar, Seemon, et al.
Publicado: (2023)

KRAS4A Directly Regulates Hexokinase 1
por: Amendola, Caroline R., et al.
Publicado: (2019)

Panx3 links body mass index and tumorigenesis in a genetically heterogeneous mouse model of carcinogen-induced cancer
por: Halliwill, Kyle D., et al.
Publicado: (2016)

Lgr6 is a stem cell marker in mouse skin squamous carcinomas
por: Huang, Phillips Y., et al.
Publicado: (2017)

Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation
por: Wang, Yongbo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kcudkvkckhbbd60fq4084jt6jq